FFA
AMPH icon

Farther Finance Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

Farther Finance Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$28.1K Buy
1,088
+314
+41% +$6.79K ﹤0.01% 3880
2026
Q2 		$15.7K Sell
774
-362
-32% -$7.3K ﹤0.01% 4141
2026
Q1 		$23K Sell
1,136
-245
-18% -$5.99K ﹤0.01% 3558
2025
Q4 		$37K Buy
1,381
+437
+46% +$11.3K ﹤0.01% 3009
2025
Q3 		$25.2K Buy
944
+737
+356% +$19K ﹤0.01% 2880
2025
Q2 		$4.75K Buy
207
+72
+53% +$1.79K ﹤0.01% 3376
2025
Q1 		$3.82K Sell
135
-8
-6% -$256 ﹤0.01% 3167
2024
Q4 		$5.31K Hold
143
– – ﹤0.01% 2641
2024
Q3 		$6.93K Sell
143
-2
-1% -$88 ﹤0.01% 2515
2024
Q2 		$5.58K Buy
145
+47
+48% +$1.95K ﹤0.01% 2350
2024
Q1 		$4.26K Hold
98
– – ﹤0.01% 2141
2023
Q4 		$6.06K Buy
98
+18
+23% +$946 ﹤0.01% 1865
2023
Q3 		$3.68K Buy
80
+10
+14% +$546 ﹤0.01% 1626
2023
Q2 		$4.02K Hold
70
– – ﹤0.01% 1507
2023
Q1 		$2.63K Hold
70
– – ﹤0.01% 1539
2022
Q4 		$1.96K Buy
+70
New +$2.03K ﹤0.01% 1457

Other funds holding AMPH

GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
TC
Trust Company Manhattan, Kansas $1.15B AUM 7.83% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return
DCM
Davis Capital Management Jacksonville, Florida $167M AUM 17.17% 1-Year Est. Return

Farther Finance Advisors's AMPH Position: Q3 2026 in Review

Farther Finance Advisors increased its Amphastar Pharmaceuticals (AMPH) stake by 41% in Q3 2026, buying an estimated $6.79K and bringing the position to 1,088 shares worth $28.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3880.

Farther Finance Advisors first reported a position in AMPH in Q4 2022 and has held it in 16 quarters since. The position peaked at $37K in Q4 2025. 9 funds tracked by Wall St. Rank hold AMPH as of Q3 2026.

  • Farther Finance Advisors held 1,088 shares of Amphastar Pharmaceuticals worth $28.1K as of Q3 2026.
  • Farther Finance Advisors bought 314 Amphastar Pharmaceuticals shares in Q3 2026, an estimated $6.79K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #3880 holding.
  • Farther Finance Advisors first reported a position in Amphastar Pharmaceuticals in Q4 2022 and has held it in 16 quarters since.
  • Farther Finance Advisors's Amphastar Pharmaceuticals position peaked at $37K in Q4 2025.
  • 9 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.